Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancer

about

CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma

P2860

Q47556436-906D5DC8-F0A0-469E-8BC7-76E3BFDE7E5B Q58794926-E0910457-D7F8-4395-8006-959C5DB02FB7

P2860

Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancer

Item

http://www.wikidata.org/entity/Q36307943

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Virtual screening of natural c ...... ith non-small cell lung cancer

@ast

Virtual screening of natural c ...... ith non-small cell lung cancer

@en

type

Item

label

Virtual screening of natural c ...... ith non-small cell lung cancer

@ast

Virtual screening of natural c ...... ith non-small cell lung cancer

@en

prefLabel

Virtual screening of natural c ...... ith non-small cell lung cancer

@ast

Virtual screening of natural c ...... ith non-small cell lung cancer

@en

P1476

Virtual screening of natural c ...... ith non-small cell lung cancer

@en

P2093

Madhulata Kumari

http://www.w3.org/2001/XMLSchema#string

Mahesha Nand

http://www.w3.org/2001/XMLSchema#string

Priyanka Maiti

http://www.w3.org/2001/XMLSchema#string

Ragini Pant

http://www.w3.org/2001/XMLSchema#string

Subhash Chandra

http://www.w3.org/2001/XMLSchema#string

Veena Pande

http://www.w3.org/2001/XMLSchema#string

P2860

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

Natural products in drug discovery.

Virtual screening of AmpC/β-lactamase as target for antimicrobial resistance in Pseudomonas aeruginosa

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

A geometric approach to macromolecule-ligand interactions.

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Epidermal growth factor receptor family in lung cancer and premalignancy.

The morphological and molecular diagnosis of lung cancer.

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.

PharmaGist: a webserver for ligand-based pharmacophore detection

P304

311-317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6026/97320630012311

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293073

http://www.w3.org/2001/XMLSchema#string

P932

5320927

http://www.w3.org/2001/XMLSchema#string

Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancer

about

P2860

P2860

Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932